At Wealthy VC, we don’t just watch the ticker tape; we anticipate where the next wave of momentum will strike.…
Read More »Biotech
The last four months proved transformative for Profusa (NASDAQ: PFSA). The company emerged from a whirlwind of activity with a…
Read More »
Berkeley-based digital health innovator Profusa (NASDAQ: PFSA) just cleared a major hurdle on its path to commercialization. The company announced…
Read More »
Armata Pharmaceuticals (NYSE American: ARMP) surprised Wall Street on Wednesday after its stock rocketed as much as 370% intraday on…
Read More »
Profusa (NASDAQ: PFSA) is advancing on two fronts this month, expanding its European commercialization footprint for its Lumee™ Oxygen platform…
Read More »
Shares of Spruce Biosciences (NASDAQ: SPRB) surged 1,378% to $130.40 on Monday after the U.S. Food and Drug Administration granted…
Read More »
Profusa (NASDAQ: PFSA) is extending its footprint in European healthcare with the addition of one of France’s top vascular surgeons…
Read More »
Shares of uniQure (NASDAQ: QURE) staged one of the most dramatic rallies of the year on Wednesday, more than tripling…
Read More »
Nvidia (NASDAQ: NVDA) hasn’t just ridden the AI wave; it’s helped shape it, on the chip side and, increasingly, through…
Read More »
Profusa (NASDAQ: PFSA) is quickly building momentum across Europe, adding leading vascular specialists to its clinical network while also preparing…
Read More »